Skip to content

Clinical trials

Completed Schizophrenia trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Status: Completed Country / region: Russia Clear all

96 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20046
20054
20063
20078
20089
20099
20108
20119
20126
20139
20142
20151
20166
20175
20194
20203
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed96

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Development & Commercialization, Inc.15
Sumitomo Pharma America, Inc.9
Hoffmann-La Roche8
Eli Lilly and Company7
AstraZeneca6
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.6
Alkermes, Inc.5
Janssen Research & Development, LLC5
Denovo Biopharma LLC4
FORUM Pharmaceuticals Inc4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia96
Psychotic Disorders10
Bipolar Disorder4
Cognition Disorders3
Mental Disorders3
Recurrence2
Anxiety Disorders1
Autistic Disorder1
Central Nervous System Diseases1
Cognitive Dysfunction1

Trials

Showing 1 to 25 of 96. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.